Congenital CMV Risk Calculator
Estimate the risk of congenital cytomegalovirus infection after maternal primary infection using key clinical parameters.
Medical Recommendation
Please consult your doctor for a complete assessment.
Congenital CMV Risk Calculator – Your Advanced Tool
Congenital Cytomegalovirus (CMV) infection is a significant concern during pregnancy, as it can lead to serious health complications for the newborn. Our advanced Congenital CMV Risk Calculator is designed to help expectant mothers and healthcare providers estimate the risk of congenital CMV infection after a maternal primary infection.
How the Clinical Parameters Work
The calculator evaluates your risk profile based on four critical medical inputs:
- Health Insurance: Reflects broader statistical data on healthcare access and outcomes.
- IgG Avidity: IgG avidity testing helps determine the maturity of the immune response. High avidity (≥32%) reduces the risk of congenital transmission, while low avidity (<32%) suggests a recent primary infection.
- IgM Antibody Index: A marker of recent infection. A low index (<4.5) is favorable, whereas a high index indicates a robust immune response correlating with higher risk.
- Viral Load in Maternal Plasma: The presence of a detectable viral load is one of the most significant predictors of congenital CMV infection.
Frequently Asked Questions (FAQs)
1. What is congenital CMV infection?
Congenital CMV infection occurs when the cytomegalovirus is transmitted from a mother to her fetus during pregnancy. It can lead to a range of complications, including hearing loss and developmental delays in newborns.
2. Can I use this tool for a clinical diagnosis?
No, this tool is strictly for informational and educational purposes. It provides an estimated risk based on weighted clinical data and should be used solely as an aid for consultation with your obstetrician or healthcare provider.
3. What should I do if my calculated risk is high?
If your risk is assessed as high, it is extremely important to discuss these results with your healthcare provider immediately. They may recommend further diagnostic tests (like amniocentesis), targeted ultrasounds, or specific interventions.
1. Hughes BL, Clifton RG, Rouse DJ, et al. A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection. N Engl J Med. 2021.
2. Rouse DJ, Fette LM, Hughes BL, et al. Noninvasive Prediction of Congenital Cytomegalovirus Infection after Maternal Primary Infection. Obstet Gynecol. 2022.